Brent Meadows on Clubhouse
Updated: Oct 25, 2023
30
Followers
214
Following
May 18, 2021
Registered
@brentmeadows
Username
Bio
OncoOne’s Chief Business Officer and US General Manager
OncoOne has identified, named, and now has created optimized mAbs targeting the disease-related isoform of the macrophage migration inhibitory factor — oxMIF. MIF is well known to control many important aspects of tumor immunity as well as our innate and adaptive immune systems.
📍Boston 🧬
OncoOne 📍Vienna, Austria
Invited by: Debbie Moynihan
Last 10 Records
if the data has not been changed, no new rows will appear.
| Day | Followers | Gain | % Gain |
|---|---|---|---|
| October 25, 2023 | 30 | -1 | -3.3% |
| September 30, 2022 | 31 | +2 | +6.9% |
| August 09, 2022 | 29 | +7 | +31.9% |
| May 27, 2022 | 22 | +1 | +4.8% |
| April 19, 2022 | 21 | +3 | +16.7% |
| March 11, 2022 | 18 | +3 | +20.0% |
| January 13, 2022 | 15 | +2 | +15.4% |
| December 07, 2021 | 13 | +7 | +116.7% |
| September 22, 2021 | 6 | +1 | +20.0% |
